GLP-1/GIP chimeric peptides define the structural requirements for specific ligand-receptor interaction of GLP-1

Regulatory Peptides

Volumn 63, Issue 1, 1996, Pages 17-22

  Gallwitz, Baptist ^a   Witt, Maike ^a   Morys Wortmann, Corinna ^b   Fölsch, Ulrich R ^a   Schmidt, Wolfgang E ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

Author keywords

GIP; GLP 1; Peptide analogue; Receptor binding; RINm5F cell

Indexed keywords

GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE 1; PEPTIDE;

ARTICLE; BINDING AFFINITY; HUMAN; HUMAN CELL; INSULIN RELEASE; INSULINOMA; PRIORITY JOURNAL; RECEPTOR BINDING; STRUCTURE ACTIVITY RELATION;

EID: 0029893636     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/0167-0115(96)00019-5     Document Type: Article

References (24)

1. Brown, J.C., Mutt, V. and Pederson, R.A., Further purification of a polypeptide demonstrating enterogastrone activity, J. Physiol., 209 (1970) 57-64.
2. Creutzfeldt, W., The incretin concept today, Diabetologia, 16 (1979) 75-85.
3. Gallwitz, B., Witt, M., Fölsch, U.R. and Schmidt, W.E., Binding specificity and signal transduction of receptors for glucagon-like peptide-1(7-36)amide and gastric inhibitory polypeptide on RINm5F insulinoma cells, J. Mol. Endocrinol., 10 (1993) 259-268.
4. Amiranoff, B., Couvineau, A., Vauclin-Jacques, N. and Laburthe, M., Gastric inhibitory polypeptide receptor in hamster pancreatic beta cells, Eur. J. Biochem., 159 (1986) 353-358.
5. Amiranoff, B., Vauclin-Jacques, N. and Laburthe, M., Functional GIP receptors in a hamster pancreatic beta cell line, In 111: specific binding and biological effects, Biochem. Biophys. Res. Commun., 123 (1984) 671-676.
6. Usdin, T.B., Mezey, E., Button, D.C., Brownstein, M.J. and Bonner, T.I., Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain, Endocrinology, 133 (1993) 2861-2870.
7. Orskov, C., Glucagon-like peptide-1, a new hormone of the enteroinsular axis, Diabetologia, 35 (1992) 701-711.
8. Schmidt, W.E., Siegel, E.G. and Creutzfeldt, W., Glucagon-like peptide-1 but not glucagon-like peptide-2 stimulates insulin release from isolated rat pancreatic islets, Diabetologia, 28 (1985) 704-707.
9. Orskov, C., Holst, J.J., Knuthsen, S., Baldissera, F.G.A., Poulsen, S.S. and Vagn Nielsen, O., Glucagon-like peptides GLP-1 and GLP-2, predicted products of the glucagon gene, are secreted separately from pig small intestine, but not pancreas, Endocrinology, 119 (1986) 1467-1475.
10. Gutniak, M., Orskov, C., Holst, J.J., Ahren, B. and Efendic, S., Antidiabetogenic effect of glucagon-like peptide-1(7-36)amide in normal subjects and patients with diabetes mellitus. New Engl. J. Med., 326 (1992) 1316-1322.
11. Nauck, M.A., Heimesaat, M.M., Orskov, C., Holst, J.J., Ebert, R. and Creutzfeldt, W., Preserved incretin activity of glucagon-like peptide-1(7-36)amide but not of synthetic human gastric inhibitory polypeptide in patients with type II diabetes mellitus, J. Clin. Invest., 91 (1993) 301-307.
12. Siegel, E.G., Schulze, A., Schmidt, W.E. and Creutzfeldt W., Comparison of the effect of GIP and GLP-1(7-36)amide on insulin release from rat pancreatic islets, Eur. J. Clin. Invest., 22 (1992) 154-157.
13. Nauck, M.A., Bartels, E., Orskov, C., Ebert, R. and Creutzfeldt, W., Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1[7-36] amide infused at near-physiological insulinotropic hormone and glucose concentrations, J. Clin. Endocrin. Metab., 76 (1993) 912-917.
14. Göke, R., Cole, T. and Conlon, J.M., Characterization of the receptor for glucagon-like peptide-1(7-36)amide on plasma membranes from rat insulinoma cells by covalent cross linking, J. Mol. Endocrinol., 2 (1989) 93-98.
15. Gallwitz, B., Schmidt, W.E., Conlon, J.M. and Creutzfeldt, W., Glucagon-like peptide-1(7-36)amide: characterization of the domain responsible for binding to its receptor on rat insulinoma RINm5F cells, J. Mol. Endocrinol., 5 (1990) 33-39.
16. Thorens, B., Expression cloning of the pancreatic β-cell receptor for the gluco-incretin hormone glucagon-like peptide-1, Proc. Natl. Acad. Sci. USA, 89 (1992) 8641-8645.
17. Suzuki, S., Kawai, K., Ohashi, S., Mukai, H. and Yamashita, K., Comparison of the effects of various C-terminal and N-terminal fragment peptides of glucagon-like peptide-1 on insulin and glucagon release from the isolated perfused rat pancreas, Endocrinology, 125 (1989) 3109-3114.
18. Adelhorst, K., Hedegaard, B.B., Knudsen, L.B. and Kirk, O., Structure-activity studies of glucagon-like peptide-1, J. Biol. Chem., 269 (1994) 6275-6278.
19. Gallwitz, B., Witt, M., Paetzold, G., Morys-Wortmann, C., Zimmermann, B., Eckart, K., Fölsch, U.R. and Schmidt, W.E., Structure-activity characterization of glucagon-like peptide-1, Eur. J. Biochem., 225 (1994) 1151-1156.
20. Praz, G.A., Halban, P.A., Wolheim, C.B., Blondel, B., Strauss, A.J. and Renold, A.E., Regulation of immunoreactive insulin release from a rat cell line (RINm5F) Biochem. J., 210 (1983) 345-352.
21. Schmidt, W.E., Siegel, E.G., Kratzin, H. and Creutzfeldt, W., Isolation and primary structure of tumor-derived peptides related to human pancreastatin and chromogranin A, Proc. Natl. Acad. Sci. USA, 85 (1988) 8231-8235.
22. Schmidt, W.E., Kratzin, H., Eckart, K., Drevs, D., Mundkowski, G., Clemens, A., Katsoulis, S., Schäfer, H., Gallwitz, B. nd Creutzfeldt, W., Isolation and primary structure of pituitary human galanin, a 30-residue nonamidated neuropeptide, Proc. Natl. Acad. Sci. USA, 88 (1991) 11435-11439.
23. Gallwitz, B., Witt, M., Paetzold, G., Morys-Wortmann, C., Fölsch, U.R. and Schmidt, W.E., Binding characteristics of N-terminal GIP/GLP-1 hybrid peptides, Endocrin. Metabol., 2 (1995) 39-46.
24. Maletti, M., Carlquist, M., Portha, B., Kergoat, M., Mutt, V. and Rosselin, G., Structural requirements for gastric inhibitory polypeptide (GIP) receptor binding and stimulation of insulin release, Peptides 7, Suppl.1 (1986) 75-78.